跳至主要内容
临床试验/IRCT20201227049851N1
IRCT20201227049851N1招募中3 期

Efficacy of Memantine augmentation in moderate to severe obsessive-compulsive symptoms

Kashan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • All patients who suffer from obsessive-compulsive disorder according to DSM V and clinical interview.
  • Patients who have Yale-Brown Scores of 15 and above.
  • Patients who give written consent for participating in the study.

排除标准

  • Patients who are diagnosed with a comorbid DSM V psychiatric diagnosis.
  • Patients who suffer from any systemic disease such as diabetes, hypo and hyperthyroidism,hypertension,hepatic failure or renal failure.
  • Patients who use alcohol or any other substance.
  • Patients who have received a psychotropic medicine during the last 6 months.
  • Women who are pregnant or breastfeeding or do not use any certain contraceptive method.
  • Patients who use concomitant somatic treatments.
  • Patients who are under treatment with Acetyl Cysteine, buprenorphine or any other medicine
  • Patients who receive any kind of psychotherapies.

研究者

相似试验